Streetbeat News

Analyst Ratings

BZ

Citigroup analyst Brian Gong has initiated coverage on Kanzhun (NASDAQ:BZ) with a Buy rating and a price target of $19.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 4:10 pm

GFL

TD Securities analyst Tim James has maintained a 'Buy' rating on GFL Environmental (NYSE:GFL) and raised the price target from C$58 to C$59.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 4:09 pm

ELYM

Eliem Therapeutics Inc (NASDAQ:ELYM) shares are trading higher after the company completed a review of its business. The company has decided to halt further development of its Kv7 program and to conduct a comprehensive exploration of strategic alternatives. Eliem has engaged Leerink Partners to act as a strategic advisor. As of June 30, 2023, the company had approximately $102.6 million in cash, cash equivalents, and investments in marketable securities.

Portfolio Pulse from Vandana Singh

July 20, 2023 | 4:08 pm

SAP

SAP (NYSE:SAP) reported Q2 earnings of $1.06 per share, missing the analyst consensus estimate of $1.31 by 19.08%. The company also reported quarterly sales of $8.23 billion, missing the analyst consensus estimate of $8.51 billion by 3.30%. However, both earnings and sales show an increase compared to the same period last year.

Portfolio Pulse from Happy Mohamed

July 20, 2023 | 4:07 pm

VIR

HC Wainwright & Co. analyst Patrick Trucchio has reiterated a 'Buy' rating on Vir Biotechnology (NASDAQ:VIR) and maintained a $100 price target.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 4:07 pm

APLS

Citigroup analyst Yigal Nochomovitz has maintained a 'Buy' rating on Apellis Pharmaceuticals but lowered the price target from $106 to $80.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 4:06 pm

PZZA

OTR Global has upgraded Papa John's International from Mixed to Positive.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 4:05 pm

GS

Goldman Sachs Group Inc (GS) reported a 60% YoY decrease in Q2 earnings, marking its weakest quarter since the onset of the pandemic. Despite this, analysts from Oppenheimer, JMP, and BMO remain bullish on the bank's prospects. They cite reasons such as potential performance improvement, optimistic trends in M&A dialogue, and the emergence of 'green shoots' in the capital markets.

Portfolio Pulse from AJ Fabino

July 20, 2023 | 4:03 pm

NFLX

Oppenheimer analyst Jason Helfstein maintains an Outperform rating on Netflix (NASDAQ:NFLX) and raises the price target from $500 to $515.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 4:03 pm

GM

A significant amount of unusual options activity has been detected for General Motors (NYSE:GM), with a majority of investors taking a bullish stance. The trades range from $33.0 to $50.0. The price of GM is currently down -0.35% at $39.09. Analysts from Jefferies, Morgan Stanley, Citigroup, Barclays, and Wells Fargo have maintained their ratings on GM, with price targets ranging from $32 to $89.

Portfolio Pulse from Benzinga Insights

July 20, 2023 | 4:01 pm